Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Non-emergency urgent and routine eye care conditions managed at a variety of community-based clinic sites across Nottingham and Nottinghamshire.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| East Midlands Medical Services Limited | 09619501 | - | 1 lot Lot 1 | - |
| HealthHarmonie Limited | 04724733 | - | 1 lot Lot 1 | - |
| Primary Eye Care Services Limited | 06722353 | - | 1 lot Lot 1 | - |
This procurement was divided into 1 lots, each awarded separately. 4 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 | £9,507,584 initial term | 1 single bid — no competition | HealthHarmonie Limited East Midlands Medical Services Limited Primary Eye Care Services Limited East Midlands Medical Services Limited | active |
Weightings from the notice.
Government spending data: These suppliers have received £5,811,373 in 34 payments (over £25k) from Worcestershire Acute Hospitals NHS Trust, The Royal Wolverhampton NHS Trust, NHS England (2016-04-30 to 2026-02-28).
Changes the buyer published to this notice after it first appeared.
This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. This contract has now been formally awarded using direct award process C.
The contract was awarded for the period 1 April 2024 to 31 March 2026. The lifetime value of the contract is £9,507,584.
A provider representation was received during the standstill period. A Provider Representation Panel was convened. The membership of the panel was in line with the approved Terms of Reference. No conflicts of interest were identified.
Following the review, the Panel concluded that it was satisfied the ICB had applied the regime correctly and made the appropriate provider selection decision.